Name: Shalini Pahwa. Disease: multiple myeloma (blood cancer). Part of treatment: injection Novartis Zometa. Cost: Rs 15,200 per shot. Place of treatment: private hospital in Gurgaon.
While the cost of the injection is shocking, what is even more shocking is the fact that the same drug, under a different brand name, was available at a Delhi hospital for just Rs 800, says a new book, "Healers or Predators?"
Documenting the case of Pahwa, an article on "A Consumer's View" says, "According to an industry insider, Zometa is sold to stockists for Rs 13,000. At that rate, the hospital would make a profit of Rs 2,200. Shalini said 'she felt just fine shifting to the cheaper alternative'."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
